Evidence map›Paper›PMID 42281142›Full record

ArticlePharmacology research & perspectives2026

Patterns of Spontaneous Adverse Drug Reaction Reporting in Germany From 2012 to 2021.

Diana Dubrall, Severin Domgörgen, Patrick Christ, Maike Below, Matthias Schmid, Bernhardt Sachs

Abstract read
In one paragraph

Article in Pharmacology research & perspectives, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Diana DubrallUniversity of Bonn, University Hospital Bonn, Institute for Medical Biometry, Informatics and Epidemiology, Bonn, Germany.ORCID https://orcid.org/0000-0002-8763-051X
Severin DomgörgenUniversity of Bonn, University Hospital Bonn, Institute for Medical Biometry, Informatics and Epidemiology, Bonn, Germany.
Patrick ChristUniversity of Bonn, University Hospital Bonn, Institute for Medical Biometry, Informatics and Epidemiology, Bonn, Germany.ORCID https://orcid.org/0000-0003-3197-5639
Maike BelowCentral Research Institute for Ambulatory Health Care in Germany, Berlin, Germany.
Matthias SchmidUniversity of Bonn, University Hospital Bonn, Institute for Medical Biometry, Informatics and Epidemiology, Bonn, Germany.ORCID https://orcid.org/0000-0002-0788-0317
Bernhardt SachsResearch Division, Federal Institute for Drugs and Medical Devices (BfArM), Bonn, Germany.ORCID https://orcid.org/0000-0001-8260-0891

Funding

Bundesinstitut für Arzneimittel und MedizinprodukteUniversity Hospital Bonn V-2023.3/68502/2024-2028
6 · The paper itself

Abstract

The absolute number of spontaneous adverse drug reaction (ADR) reports increased in the past in several national and international ADR databases. However, in most studies drug exposure was not considered. Our study aimed to evaluate the number of ADR reports from Germany in relation to the number of patients with outpatient drug prescriptions stratified by sex, age groups, seriousness, and reporter types (physician versus consumer). Therefore, 407 882 spontaneous ADR reports from Germany, after exclusion of ADR reports related to vaccines, intentional misuses and accidental exposure, submitted between 01.01.2012 and 31.12.2021 were analyzed. The annual numbers of patients with at least one outpatient drug prescription were provided by the Central Research Institute for Ambulatory Health Care in Germany. Reporting rates per year were calculated by dividing the annual number of spontaneous ADR reports by the annual number of patients with at least one outpatient drug prescription. Between 2012 and 2021 (2.4-fold), and strikingly between 2017 and 2018 (2.2-fold), the annual reporting rate increased. This increase appears to be primarily driven by non-serious ADR reports submitted by consumers (32.5-fold increase), whereas reporting rates for serious ADRs and for reports submitted by physicians remained stable. Furthermore, the rise of non-serious ADR reports from consumers was particularly apparent for females aged 12-17 and 18-64 years. Overall, the observed increase of non-serious ADR reports is most likely related to changes in reporting obligations for pharmaceutical companies. Our study suggests that females might report ADRs more frequently.

Indexed as

Adverse Drug Reaction Reporting SystemsDrug-Related Side Effects and Adverse ReactionsAdolescentAdultAgedAged, 80 and overChildChild, PreschoolDatabases, FactualFemaleGermanyHumansInfantInfant, NewbornMaleMiddle Agedadverse drug reactionsreporting patternsreporting ratesspontaneous reporting databasespontaneous reports

Identifiers

PMID42281142
PMCPMC13260685

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.